MedPath

Cytogenetic Analysis of Bone Marrow Specimen Prior to High Dose Chemotherapy and Autologous Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease

Not Applicable
Completed
Conditions
Lymphoma, Non-Hodgkin
Hodgkin Disease
Registration Number
NCT00534820
Lead Sponsor
King Faisal Specialist Hospital & Research Center
Brief Summary

Cytogenetic Analysis of Bone Marrow Specimen Prior to High Dose Chemotherapy and Autologous Stem Cell Transplantation in Patients with Non-Hodgkin's Lymphoma or Hodgkin's Disease

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
450
Inclusion Criteria
  • Patients with Non-Hodgkin's Lymphoma or Hodgkin's Disease
Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Efficacy6 years
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

KFSH&RC

🇸🇦

Riyadh, Saudi Arabia

© Copyright 2025. All Rights Reserved by MedPath